These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 11711002)

  • 41. Controversies in primary prevention among hyperlipidemic patients.
    McPherson R
    Can J Cardiol; 1999 Apr; 15 Suppl B():16B-19B. PubMed ID: 10350678
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia: a post Hoc analysis of subpopulations from three pooled clinical trials.
    Feldman T; Davidson M; Shah A; Maccubbin D; Meehan A; Zakson M; Tribble D; Veltri E; Mitchel Y
    Clin Ther; 2006 Jun; 28(6):849-59. PubMed ID: 16860168
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cholesterol-lowering drugs for primary prevention? The WOSCOP Study.
    Muntoni S
    Pharmacol Res; 1997 Mar; 35(3):169-70. PubMed ID: 9229402
    [No Abstract]   [Full Text] [Related]  

  • 44. Cholesterol-lowering and vascular reactivity in relation to coronary heart disease.
    de Divitiis M; Rubba P
    Nutr Metab Cardiovasc Dis; 1999 Jun; 9(3):133-42. PubMed ID: 10464786
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Coronary heart disease: grave deficiencies in secondary prevention. Almost no one is concerned with blood lipids].
    Arnheim K
    MMW Fortschr Med; 2000 Jun; 142(24):18. PubMed ID: 10895577
    [No Abstract]   [Full Text] [Related]  

  • 46. [New results in the management of hypercholesterolemia].
    Sármán B
    Orv Hetil; 2005 Sep; 146(39):1999-2004. PubMed ID: 16265867
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [A new study on hypercholesterolemia. Statin is effective against heart disease].
    Olsson AG
    Lakartidningen; 1996 May; 93(22):2131-3. PubMed ID: 8667843
    [No Abstract]   [Full Text] [Related]  

  • 48. Cost-effectiveness of pravastatin for primary prevention of coronary artery disease in Japan.
    Nagata-Kobayashi S; Shimbo T; Matsui K; Fukui T
    Int J Cardiol; 2005 Sep; 104(2):213-23. PubMed ID: 16168816
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Heart magnyl or statins?].
    Astrup P; Gyntelberg F
    Ugeskr Laeger; 1998 Dec; 160(51):7455. PubMed ID: 9889668
    [No Abstract]   [Full Text] [Related]  

  • 50. [Effect of pharmacological interventions on progression of coronary atherosclerosis].
    Navarro A
    Rev Esp Cardiol; 1996 May; 49(5):389-90. PubMed ID: 8744396
    [No Abstract]   [Full Text] [Related]  

  • 51. Primary prevention of coronary heart disease in the elderly.
    Dornbrook-Lavender KA; Pieper JA; Roth MT
    Ann Pharmacother; 2003 Nov; 37(11):1654-63. PubMed ID: 14565805
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [AFCAPS/TexCAPS [The Air Force/Texas Coronary Atherosclerosis Prevention Study]].
    Goto Y
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():398-403. PubMed ID: 11347102
    [No Abstract]   [Full Text] [Related]  

  • 53. Statins: new data in secondary prevention and diabetes. Pravastatin and simvastatin are the best-assessed statins.
    Prescrire Int; 2003 Aug; 12(66):143-8. PubMed ID: 12908497
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pravastatin and coronary heart disease.
    Assmann G; Schulte H; Cullen P
    Circulation; 1998 Dec 22-29; 98(25):2933-4. PubMed ID: 9860800
    [No Abstract]   [Full Text] [Related]  

  • 55. High cholesterol levels in healthy seniors: cause for concern?
    Drown DJ
    Prog Cardiovasc Nurs; 1995; 10(1):40-1. PubMed ID: 7770441
    [No Abstract]   [Full Text] [Related]  

  • 56. Achieving lipid goals in real life: the Dutch DISCOVERY study.
    Bots AF; Kastelein JJ;
    Int J Clin Pract; 2005 Dec; 59(12):1387-94. PubMed ID: 16351669
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term follow-up of the West of Scotland Coronary Prevention Study.
    DeFilippis AP; Bansal S; Blumenthal RS
    N Engl J Med; 2008 Jan; 358(2):194; author reply 194-5. PubMed ID: 18193527
    [No Abstract]   [Full Text] [Related]  

  • 58. Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study.
    Colquhoun D; Keech A; Hunt D; Marschner I; Simes J; Glasziou P; White H; Barter P; Tonkin A;
    Eur Heart J; 2004 May; 25(9):771-7. PubMed ID: 15120888
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evidence mandating earlier and more aggressive treatment of hypercholesterolemia.
    Steinberg D; Glass CK; Witztum JL
    Circulation; 2008 Aug; 118(6):672-7. PubMed ID: 18678783
    [No Abstract]   [Full Text] [Related]  

  • 60. Lipid-lowering therapy and risk of coronary events.
    Blakely JA
    JAMA; 2003 Apr 23-30; 289(16):2070-1; author reply 2071-2. PubMed ID: 12709461
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.